Gabon Pharmaceuticals and Healthcare Report

 Published On: Aug, 2016 |    No of Pages: 55 |  Published By: BMI Pharmaceuticals and Healthcare | Format: PDF
Request Free Sample

BMI View: Gabon's small pharmaceutical market will continue to act as a deterrent to any local investments by multinational drugmakers. Opportunities will be largely focused within the generic drug market, yet over the long term, as the national health insurance scheme gains momentum, this will provide greater momentum for pharmaceutical expenditure. The Gabonese government will struggle to increase funding for healthcare to the 15% target set at the Abuja declaration, and the country will continue to rely on aid funding from external organisations.

Headline Expenditure Projections
-Pharmaceuticals: XAF48.1bn (USD81mn) in 2015 to XAF49.9bn (USD81mn) in 2016; +3.7% in local currency and 0.0% in US dollar terms. Forecast unchanged from Q316.
-Healthcare: XAF310.5bn (USD524mn) in 2015 to XAF329.05bn (USD537mn) in 2016; +6.1% in local currency and +2.4% in US dollar terms. Forecast revised upwards from Q316.

BMI Industry View ...... 7
Table: Headline Pharmaceuticals & Healthcare Forecasts (Gabon 2014-2020) . 7
SWOT ...... 9
Industry Forecast ..... 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Gabon 2012-2020) . . 13
Healthcare Market Forecast ...... 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Gabon 2012-2020) . . 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Gabon 2012-2020) . . . 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Gabon 2012-2020) . . . 17
Pharmaceutical Trade Forecast . 18
Table: Pharmaceutical Trade Data And Forecasts local currency (Gabon 2014-2020) . . 19
Table: Pharmaceutical Trade Data And Forecasts (Gabon 2014-2020) . . . . 20
Industry Risk/Reward Index .. 21
Middle East and Africa Risk/Reward Index - Q4 2016 . 21
Gabon Risk/Reward Index .. 29
Rewards ... 29
Risks . 29
Regulatory Review ... 31
Regulatory Environment ... 31
Regulatory Regime ... 31
Intellectual Property Issues ...... 32
Pricing Regime . 32
Reimbursement Regime .... 32
Market Overview ...... 34
Healthcare Sector .... 34
Research & Development . 37
Clinical Trials .. 37
Epidemiology ... 38
Competitive Landscape .. 41
Research-Based Industry .. 41
Table: Multinational Market Activity 42
Generic Drugmakers 42
Pharmaceutical Distribution .... 43
Pharmaceutical Retail Sector ... 43
Demographic Forecast ... 44
Table: Population Headline Indicators (Gabon 1990-2025) . 45
Table: Key Population Ratios (Gabon 1990-2025) . 45
Table: Urban/Rural Population & Life Expectancy (Gabon 1990-2025) . . . 46
Table: Population By Age Group (Gabon 1990-2025) . . 46
Table: Population By Age Group % (Gabon 1990-2025) . . . . 47
Glossary ...... 49
Methodology ...... 51
Pharmaceutical Expenditure Forecast Model ... 51
Healthcare Expenditure Forecast Model ... 51
Notes On Methodology ..... 52
Risk/Reward Index Methodology ...... 53
Index Overview . 54
Table: Pharmaceutical Risk/Reward Index Indicators . . 54
Indicator Weightings 55
If the above report does not have the information suitable for your business, we can provide custom research that can be lucrative for your business or enhance your profession.